Neogenomics (NEO) Gross Profit Growth (1y) (2011 - 2026)
Neogenomics (NEO) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.50% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 40.07% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.47% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 12.14% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 12.13% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 6.29% |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | 18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.92% |
| Mar 31, 2026 | 10.40% |
| Dec 31, 2025 | 7.88% |
| Sep 30, 2025 | 7.43% |
| Jun 30, 2025 | 6.57% |
| Mar 31, 2025 | 11.88% |
| Dec 31, 2024 | 14.31% |
| Sep 30, 2024 | 20.17% |
| Jun 30, 2024 | 21.04% |
| Mar 31, 2024 | 19.44% |
| Dec 31, 2023 | 18.94% |
| Sep 30, 2023 | 27.44% |
| Jun 30, 2023 | 36.28% |
| Mar 31, 2023 | 43.37% |
| Dec 31, 2022 | 25.56% |
| Sep 30, 2022 | 3.50% |
| Jun 30, 2022 | -17.07% |
| Mar 31, 2022 | -8.04% |
| Dec 31, 2021 | -21.23% |
| Sep 30, 2021 | -12.63% |